Ministry of Health of the Slovak Republic in accordance with § 60 (1) point. (a) Act No 140/1998 Coll. on medicinal products and medical devices, amending Act No 455/1991 On 30 November 2010, the Commercial Business Act, as amended, and the amendment of the Law of the National Council of the Slovak Republic No 220/1996 Coll. on Advertising as amended (hereinafter "the Act') approved the Expert Guideline MZ SR No: OF/1511/2010, which regulates the number of packs of drug precursor products required for one treatment cycle. The Annex to the Expert Guideline sets out the number of packs of the drug precursor product required for one treatment cycle for the purpose of dispensing the medicinal product under Articles 35 (4) and 38 (7) of the Act.

This number was established according to a valid summary of product characteristics approved at the marketing authorisation and included in the marketing authorisation for the medicinal product containing the drug precursor.

Pursuant to Articles 35 (4) and 38 (7) of the Law, a person authorised to dispense medicinal products obtained without a prescription may dispense a drug containing a drug precursor only in the number of packs in which it is necessary for one treatment cycle.

The aim of the Technical Guidelines is to ensure equal treatment in all public pharmacies for the dispensing and dispensing of medicinal products containing a drug precursor which are obtained without a prescription.


Expert Guideline of the Ministry of Health of the Slovak Republic No: OF/1511/2010 of 30 November 2010 governing the number of packs of drug precursor medicinal product required for one treatment cycle

Ministry of Health of the Slovak Republic pursuant to § 60 (1) (a). (a) Act No 140/1998 Coll. on medicinal products and medical devices, amending Act No 455/1991 The following expert guidance is issued on trade (Civic Law), as amended, and on the amendment of the Law of the National Council of the Slovak Republic No 220/1996 Coll. on Advertising, as amended, (hereinafter "the Act'):

Art. 1

The number of packs of drug precursor medicinal product required for one treatment cycle for the purpose of dispensing the medicinal product pursuant to Articles 35 (4) and 38 (7) of the Act is listed in an annex to this Expert Guideline.

Art. 2

This expert guidance takes effect on the date of publication in the Journal of the Ministry of Health of the Slovak Republic.

Ivan Uhliarik, v. r.,
minister


Annex to Expert Guideline OF/1511/2010

Number of packs of the drug precursor product needed per treatment cycle

Code
ŠÚKL
NameAppendixDrug precursor content in the drug unit
formulation
Content of the drug precursor in the packageMaximum use duration according to the SPCNumber of packs per treatment cycleTotal amount of drug precursor
52368COMPLEX ASSPIRIN10 (5x2)30 mg3003 days (without consulting your doctor)2600
52369COMPLEX ASSPIRINgru por 20 (10x2)30 mg6003 days (without consulting your doctor)1600
40094DALERON COLD3tbl flm 2430 mg720not specified1720
40089DALERON COLD3tbl flm 1230 mg360not specified2720
40088DALERON COLD3tbl flm 1030 mg300not specified2600
45935MODAFENtbl flm 1030 mg3005 days2600
7987MODAFENtbl flm 1230 mg3605 days2720
11024MODAFENtbl flm 2430 mg7205 days1720
87178NUROFENSTOPGRIPtbl flm 1230 mg3605 days2720
87179NUROFENSTOPGRIPtbl flm 2430 mg7205 days1720
40802PANADOLPLUSGRIPtbl flm 2 (bl.)30 mg605 days12720
40803PANADOLPLUSGRIPtbl flm 5 (blist)30 mg1505 days4600
40809PANADOLPLUSGRIPtbl flm 24 (blist)30 mg7205 days1720
40804PANADOLPLUSGRIPtbl flm 6 (blist)30 mg1805 days4720
40805PANADOLPLUSGRIPtbl flm 10 (blist)30 mg3005 days2600
40806PANADOLPLUSGRIPtbl flm 12 (blist)30 mg3605 days2720
40807PANADOLPLUSGRIPtbl flm 16 (blist)30 mg4805 days1480
40808PANADOLPLUSGRIPtbl flm 18 (blist)30 mg5405 days1540
30228PARALEN PLUStbl flm 1230 mg3605 days2720
40090PARALEN PLUStbi flm 1030 mg3005 days2600
30229PARALEN PLUStbl flm 2430 mg7205 days1720